Erasca ERAS
NASDAQ ERAS
$15.48 -0.13 (-0.83%)
At close: Nov 10, 2026 · 4:00 PM EST

Erasca (ERAS) Preferred Stock Liabilities (2020 - 2021)

Updated

Erasca's Preferred Stock Liabilities came in at $340.8 million for Q2 2021, up 88.2% from $181.05 million a year earlier and unchanged from the prior quarter.

Analysis

Erasca (ERAS) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Erasca's Preferred Stock Liabilities was $221.41 million.

  • Business Quant data shows ERAS's Preferred Stock Liabilities at $340.8 million (Q1 2021), $221.41 million (Q4 2020) and $191.4 million (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Erasca 4.84 Bn 3.76 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 221.41 Mn
Sep 30, 2021 221.41 Mn
Jun 30, 2021 340.80 Mn
Mar 31, 2021 340.80 Mn
Dec 31, 2020 221.41 Mn
Sep 30, 2020 191.40 Mn
Jun 30, 2020 181.05 Mn
API Access

Erasca Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ERAS&period=max&api_key=YOUR_API_KEY